This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Dow Drops as Manufacturing Sector Shows Weakness, Nasdaq Slides as Biotechs Decline

NEW YORK (TheStreet) -- U.S. markets closed lower Monday, ceding early gains after poor manufacturing data in the U.S. and China, the world's first- and second-largest economies.

  • The Dow Jones Industrial Average lost 0.16% to 16,276.89, while the S&P 500 was off 0.49% to 1,857.46. The Nasdaq shed 1.18% to 4,226.38, as biotech stocks declined.
  • Biotechs continue to lose their bloom, with the S&P 500 biotech index falling more than 4% in afternoon trade on Monday after a dive of more than 5% on Friday. Friday's sector loss -- the steepest since late 2011 -- was triggered by a letter from the House Energy and Commerce committee to the chief executive of Gilead Sciences (GILD), questioning company plans to sell a hepatitis C treatment for $84,000 a dose. Mylan (MYL) closed 4.2% lower on Monday, while Gilead was broadly flat after shedding nearly 5% on Friday.
  • U.S. manufacturing activity slowed in March after a near four-year high last month, with the Markit preliminary U.S. Manufacturing Purchasing Managers Index slipping to 55.5 from 57.1 in February. The result fell short of expectations of a reading of 56.5. The flash Markit/HSBC China Manufacturing PMI showed a decline to an eight-month low of 48.1 in March. On a positive note, new export orders increased for the first time in four months, while the weak headline PMI data helped sparked stimulus chatter. The flash eurozone PMI Composite Output Index fell to a 2-month low of 53.2 in March.
  • Apple (AAPL) shares added 1.2% after The Wall Street Journal reported that the company was in talks with Comcast about teaming up for a streaming-television service that would use an Apple set-top box and get special treatment on Comcast's cables to ensure it bypasses congestion on the Web. Herbalife (HLF) popped more than 6.5% after announcing that it was nominating three additional Carl Icahn designees to its board. Also, it was reported that Cisco (CSCO) was planning a global intercloud network of public, private and hybrid cloud environments as well as plans to invest more than $1 billion to expand its cloud business during the next two years. Top losers in the S&P included Alexza Pharmaceuticals (ALXA)Netflix (NFLX) and Facebook (FB). Top losers in the Dow included Pfizer (PFE) and Merck (MRK).
  • President Obama will meet this week G-7 leaders in response to the crisis in Ukraine.
  • International markets were mixed. The FTSE 100 was 0.56% lower, the DAX in Germany was off 1.65%, the Nikkei 225 in Japan finished up 1.77%, while the Hong Kong Hang Seng rose 1.91%. Benchmark U.S. stock indices closed lower Friday, as investors balanced data showcasing the strength of the economic recovery against the nervousness around a hike in rate guidance from the Federal Reserve. Volatility played a role in Friday's market action due to options expirations.
  • In other news, Malaysia's prime minister said the long-missing Malaysian Airlines flight 370 crashed in the southern Indian Ocean, with no survivors.


-- Written by Jane Searle, Andrea Tse and Joe Deaux in New York

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,718.24 +40.34 0.24%
S&P 500 1,953.74 +2.92 0.15%
NASDAQ 4,463.0780 +10.2860 0.23%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs